scispace - formally typeset
S

Stephen Chang

Researcher at Stanford University

Publications -  13
Citations -  1346

Stephen Chang is an academic researcher from Stanford University. The author has contributed to research in topics: Gene & Cardiomyopathy. The author has an hindex of 6, co-authored 10 publications receiving 723 citations. Previous affiliations of Stephen Chang include Harvard University.

Papers
More filters
Journal ArticleDOI

A molecular cell atlas of the human lung from single-cell RNA sequencing.

TL;DR: Droplet- and plate-based single cell RNA sequencing applied to ~75,000 human cells across all lung tissue compartments and circulating blood, combined with a multi-pronged cell annotation approach, have allowed them to define the gene expression profiles and anatomical locations of 58 cell populations in the human lung.
Journal ArticleDOI

Genetics of hypertrophic cardiomyopathy.

TL;DR: The current repertoire of HCM genes allows effective gene-based diagnosis, information that enables accurate assessment of disease risk in family members, and provides some insight into clinical course.
Journal ArticleDOI

Connexin43 Modulates Cell Polarity and Directional Cell Migration by Regulating Microtubule Dynamics

TL;DR: The essential role of Cx 43 gap junctions in development is mediated by regulation of the tubulin cytoskeleton and cell polarity by Cx43 via a nonchannel function.
Posted ContentDOI

A molecular cell atlas of the human lung from single cell RNA sequencing

TL;DR: This comprehensive molecular atlas elucidates the biochemical functions of lung cell types and the cell-selective transcription factors and optimal markers for making and monitoring them; defines the cell targets of circulating hormones and predicts local signaling interactions; and identifies the cell types directly affected by lung disease genes.
Journal ArticleDOI

Molecular profiling of dilated cardiomyopathy that progresses to heart failure

TL;DR: This article performed RNA-seq at different stages of disease to define molecular signaling in the progression from pre-DCM hearts to DCM and overt heart failure (HF) using a genetic model of DCM (phospholamban missense mutation, PLNR9C/+).